Sign in
4

Changes in Ownership

Insight Molecular Diagnostics Inc. Filed Acc 0001493152-22-023380

Director bought 25,000 shares at $0.93 ($23,250)

  • Director acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gutfreund John Peter · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-15 Grant or award : show line 1 in the form +10,000 10,000 D
2022-08-15 Purchase : show line 2 in the form +25,000 $0.93 $23,250 25,000 I
Open-market purchases · 25,000 sh · avg $0.93 · $23,250

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-15 Grant or award : show line 3 in the form Option to Purchase Common Stock +45,000 45,000 D
Loading xslF345X03/ownership.xml…